We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Available until 6/1/2021

Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now

Journal Scan / Consensus and Guidelines · April 09, 2021

EASL Position Paper on COVID-19 Vaccine Use in the Chronic Liver Disease Population

Journal of Hepatology




This abstract is available on the publisher's site.

Access this abstract now  

Additional Info

Journal of Hepatology
EASL Position Paper on the Use of COVID-19 Vaccines in Patients With Chronic Liver Diseases, Hepatobiliary Cancer and Liver Transplant Recipients
J. Hepatol. 2021 Apr 01;74(4)944-951, M Cornberg, M Buti, CS Eberhardt, PA Grossi, D Shouval

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading